Myeloma UK

Recent papers from Myeloma UK

1. AI-assisted thematic synthesis of existing neurological core outcome sets: A descriptive reference framework (COS-Neuro)PLoS ONE · 2026
2. “You lose a day for every appointment”: A qualitative study of how rural versus urban residence shapes cancer care experiences in Northeast ScotlandSupportive Care in Cancer · 2026
3. Early diagnosis of AL amyloidosis in haematology, cardiology, neurology, renal and general clinics: A British Society for Haematology GuidelineBritish Journal of Haematology · 2026
4. Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholdersFrontiers in Hematology · 2026
5. Accelerating diagnosis of degenerative cervical myelopathy through improved education: a mixed-methods study protocol from Myelopathy.org RECODE-DCM to define stakeholders, knowledge requirements and an optimal intervention strategyBMJ Open · 2026
6. Translation approaches to support systemic anti-cancer therapy consent for individuals with limited English proficiencySupportive Care in Cancer · 2026
7. Frameworks and Strategies to Improve Inclusion of Underserved Groups in Myeloma Clinical Trials (EQUAL-ME Project): A Scoping Review Protocol2026
8. P17.38.b the Use of Eortc QLQ-C30 Summary Score in Cancer Clinical Trials and Its Performance as Compared With the Global Health / Quality of Life Scale: A Comparative Analysis of Effect SizesNeuro-Oncology · 2025
9. A burden too high for CAR T cells in CLLBlood · 2025
10. Kinetic Dissection of the Reaction of Human GDP-l-Fucose SynthaseACS Catalysis · 2025
11. Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced statesNeoplasia · 2025
12. Minimal Residual Disease Testing Infrastructure in Multiple Myeloma: Guidance for Clinical Trial and Routine Practice Use in CanadaClinical Lymphoma Myeloma & Leukemia · 2025
13. What is the role of non-surgical clinicians in the assessment and management of degenerative cervical myelopathy? – Insights from the RECODE-DCM peri-operative rehabilitation incubatorBrain and Spine · 2025
14. Evaluation of Financial Support Workshops for Patients Under State Pension Age With Degenerative Cervical Myelopathy: Survey StudyJMIR Formative Research · 2024
15. A minimum data set—Core outcome set, core data elements, and core measurement set—For degenerative cervical myelopathy research (AO Spine RECODE DCM): A consensus studyPLoS Medicine · 2024
16. Protocol for the process evaluation of a cluster randomised trial of audit and feedback and in practice educational training to reduce antibiotic prescribing in dental primary care: the TiPTAP trial.2024
17. National myeloma patient survey shows continuing inappropriate imaging and geographical inequalitiesBritish Journal of Radiology · 2024
18. Update and European consensus on a patient-centered core outcome set for multiple myeloma in clinical practice and researchHaematologica · 2024
19. Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myelomaHaematologica · 2024
20. Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology servicesBritish Journal of Haematology · 2024